1. Li, Xuelu, Song, Xiaoqing, Ma, Jing, Zhao, Zuowei, Li, Man. 2019. FSIP1 is correlated with estrogen receptor status and poor prognosis. In Molecular carcinogenesis, 59, 126-135. doi:10.1002/mc.23134. https://pubmed.ncbi.nlm.nih.gov/31713931/
2. Liu, Tong, Zhang, Hao, Sun, Li, Yuen, Tony, Liu, Caigang. 2017. FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness. In Proceedings of the National Academy of Sciences of the United States of America, 114, 7683-7688. doi:10.1073/pnas.1621486114. https://pubmed.ncbi.nlm.nih.gov/28674022/
3. Wu, Hui-Ying, Yang, Bin, Geng, Dong-Hua. . Clinical significance of expression of fibrous sheath interacting protein 1 in colon cancer. In World journal of gastrointestinal oncology, 12, 677-686. doi:10.4251/wjgo.v12.i6.677. https://pubmed.ncbi.nlm.nih.gov/32699582/
4. Yan, Meisi, Wang, Jinsong, Ren, Yanlv, Liu, Tong, Li, Zhigao. 2019. Over-expression of FSIP1 promotes breast cancer progression and confers resistance to docetaxel via MRP1 stabilization. In Cell death & disease, 10, 204. doi:10.1038/s41419-018-1248-8. https://pubmed.ncbi.nlm.nih.gov/30814489/
5. Kim, Jason Yongha, Kim, Jeong Hyun, Park, Tae Joon, Park, Choon-Sik, Shin, Hyoung Doo. 2010. Positive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: a case-case study. In BMC pulmonary medicine, 10, 34. doi:10.1186/1471-2466-10-34. https://pubmed.ncbi.nlm.nih.gov/20513247/
6. Sun, Ming, Chen, Zhaofu, Tan, Shutao, Liu, Caigang, Zhao, Wenyan. 2018. Knockdown of fibrous sheath interacting protein 1 expression reduces bladder urothelial carcinoma cell proliferation and induces apoptosis via inhibition of the PI3K/AKT pathway. In OncoTargets and therapy, 11, 1961-1971. doi:10.2147/OTT.S158275. https://pubmed.ncbi.nlm.nih.gov/29670371/
7. Mao, Yuqiang, Xu, Ran, Liu, Xiaoying, Shi, Wenjun, Han, Yun. . Elevated fibrous sheath interacting protein 1 levels are associated with poor prognosis in non-small cell lung cancer patients. In Oncotarget, 8, 12186-12193. doi:10.18632/oncotarget.14575. https://pubmed.ncbi.nlm.nih.gov/28086239/
8. Karagas, Margaret R, Andrew, Angeline S, Nelson, Heather H, Guerinot, Mary-Lou, Kelsey, Karl T. 2011. SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer. In Human genetics, 131, 453-61. doi:10.1007/s00439-011-1090-x. https://pubmed.ncbi.nlm.nih.gov/21947419/
9. Chen, Mengyun, Wu, Yaxing, Li, Wenjing, Zhang, Xuejun, Zhang, Bo. 2020. Loss-of-function variants in FSIP1 identified by targeted sequencing are associated with one particular subtype of mucosal melanoma. In Gene, 759, 144964. doi:10.1016/j.gene.2020.144964. https://pubmed.ncbi.nlm.nih.gov/32717308/
10. Liu, Yao, Jiang, Xinju, Yan, Xiuchun, You, Qi, Zhang, Lei. 2024. Elevated mRNA level indicates FSIP1 promotes EMT and gastric cancer progression by regulating fibroblasts in tumor microenvironment. In Open medicine (Warsaw, Poland), 19, 20240964. doi:10.1515/med-2024-0964. https://pubmed.ncbi.nlm.nih.gov/38737444/
智鼠故事 
